List of Contents

Endocrine Testing Market Size, Share, and Trends 2024 to 2034

The global endocrine testing market size is calculated at USD 14.39 billion in 2024, grew to USD 15.63 billion in 2025, and is predicted to hit around USD 32.83 billion by 2034, poised to grow at a CAGR of 8.6% between 2024 and 2034. The North America endocrine testing market size accounted for USD 5.90 billion in 2024 and is anticipated to grow at the fastest CAGR of 8.73% during the forecast year.

  • Last Updated : October 2024
  • Report Code : 3211
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Endocrine Testing Market 

5.1. COVID-19 Landscape: Endocrine Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Endocrine Testing Market, By Test Type

8.1. Endocrine Testing Market, by Test Type, 2024-2034

8.1.1 Estradiol (E2) Test

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Dehydroepiandrosterone Sulfate (DHEAS) Test

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Progesterone Test

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Testosterone Test

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Thyroid Stimulating Hormone (TSH) Test

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Prolactin Test

8.1.6.1. Market Revenue and Forecast (2021-2034)

8.1.7. Follicle Stimulating Hormone (FSH) Test

8.1.7.1. Market Revenue and Forecast (2021-2034)

8.1.8. Human Chorionic Gonadotropin (hCG) Hormone Test

8.1.8.1. Market Revenue and Forecast (2021-2034)

8.1.9. Luteinizing Hormone (LH) Test

8.1.9.1. Market Revenue and Forecast (2021-2034)

8.1.10. Cortisol Test

8.1.10.1. Market Revenue and Forecast (2021-2034)

8.1.11. Insulin Test

8.1.11.1. Market Revenue and Forecast (2021-2034)

8.1.12. Others

8.1.12.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Endocrine Testing Market, By Technology

9.1. Endocrine Testing Market, by Technology, 2024-2034

9.1.1. Immunoassay

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Chromatography

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Mass Spectroscopy

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Nucleic Acid Based

9.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Endocrine Testing Market, By End-User 

10.1. Endocrine Testing Market, by End-User, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Commercial Laboratories

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Ambulatory Care Centers

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Endocrine Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.1.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.3. Market Revenue and Forecast, by End-User (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End-User (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End-User (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.3. Market Revenue and Forecast, by End-User (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End-User (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End-User (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End-User (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End-User (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.3. Market Revenue and Forecast, by End-User (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End-User (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End-User (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End-User (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End-User (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.3. Market Revenue and Forecast, by End-User (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End-User (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End-User (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End-User (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End-User (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.3. Market Revenue and Forecast, by End-User (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End-User (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Test Type (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End-User (2021-2034)

Chapter 12. Company Profiles

12.1. Abbott Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. bioMerieux SA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Bio-Rad Laboratories Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DiaSorin S.p.A.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. F. Hoffmann-La Roche Ltd.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. AB Sciex

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Agilent Technologies Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Ortho Clinical Diagnostics

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Laboratory Corporation of America Holdings

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Quest Diagnostics Incorporated

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client